Clinical trial
Tobramycin Administered by eFlow Rapid Nebulizer: Pharmacokinetic Study
NCT00420836 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00420836 |
|---|---|
| Title | Tobramycin Administered by eFlow Rapid Nebulizer: Pharmacokinetic Study |
| Official title | Crossover Pharmacokinetic Study of Tobramycin Administered for Inhalation by PARI eFlow® Rapid Electronic Nebulizer (no Compressor) vs. PARI LC PLUSTM Jet Nebulizer (With Compressor) in Cystic Fibrosis Subjects |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cystic Fibrosis |
| Intervention type | Drug |
| Interventions | Tobramycin |
| Enrollment | 20 |
| Start date | Apr 1, 2006 |
| First posted | Jan 11, 2007 |
| Last update posted | Jan 11, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: